Enterprise Pathology Laboratory Information System

The Hon. K.J. MAHER (Leader of the Opposition) (14:50): A supplementary arising from the original answer: on what date did the minister instruct his department to make those patients affected aware of these concerns?

The Hon. S.G. WADE (Minister for Health and Wellbeing) (14:51): The department has well-established processes for open disclosure. My recollection is that every briefing I have received in relation to patient impacts has referred to open disclosure procedures being complied with.